The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne

NCT ID: NCT03650881

Last Updated: 2020-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-07

Study Completion Date

2020-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-center prospective study of two standard-of-care treatments to evaluate the efficacy of the Neutrogena® Light Therapy Acne Mask an Over the Counter (OTC) Blue/Red light LED mask, as compared to the combination of topical OTC benzoyl peroxide 2.5% gel and OTC adapalene 0.1% gel, for the treatment of mild-to-moderate facial acne. This will be an investigator-blinded, randomized, 12-week study to observe these over the counter treatments. The two arms will be: (1) Neutrogena® Light Therapy Acne Mask (MASK), (2) topical OTC benzoyl peroxide 2.5% gel and OTC adapalene 0.1% gel (TOP). Both treatment groups in this study will also receive and use standardized, non-medicated cleansing and moisturizing products. All products will be purchased through commercial sources.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neutrogena ® Light Therapy Acne Mask (MASK)

Over-the-counter powered light-based device for the treatment of acne

Group Type EXPERIMENTAL

Neutrogena ® Light Therapy Acne Mask (MASK)

Intervention Type DRUG

Daily use of the OTC Neutrogena Light Therapy Acne Mask once daily for 10 minutes

Topical benzoyl peroxide 2.5% gel and OTC adapalene

Over-the-counter medication for the treatment of acne + 0.1% Adepalene Gel

Group Type ACTIVE_COMPARATOR

Topical OTC benzoyl peroxide 2.5% gel and OTC adapalene

Intervention Type DRUG

Daily treatment with Reference Therapy OTC topical generic benzoyl peroxide 2.5% gel in the morning and OTC generic adapalene 0.1% gel at night

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neutrogena ® Light Therapy Acne Mask (MASK)

Daily use of the OTC Neutrogena Light Therapy Acne Mask once daily for 10 minutes

Intervention Type DRUG

Topical OTC benzoyl peroxide 2.5% gel and OTC adapalene

Daily treatment with Reference Therapy OTC topical generic benzoyl peroxide 2.5% gel in the morning and OTC generic adapalene 0.1% gel at night

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of acne vulgaris as determined by the study physician
* Mild-to-moderate acne defined as a grade 2 or 3 on the FDA Investigator Global Acne Assessment (IGA) for Acne vulgaris (Appendix 1)19
* If female,

* Negative urine pregnancy test at the time of enrollment and negative urine pregnancy tests at follow up visits
* Agreement to comply with medically acceptable forms of birth control with heterosexual intercourse
* Agreement to comply with the study protocol and attend all study visits

Exclusion Criteria

* Is unwilling to participate in the survey
* Outside of specified age range
* Patients with clear, almost clear acne, or severe acne defined as grade 0-1 or 4 on the IGA Scale
* Females who are pregnant or breastfeeding
* Known allergy to any ingredients in the test products or history of photosensitivity
* Pre-existing facial dermatologic conditions including excoriations that could interfere with the outcome of this study and quantification of acne lesions
* Excessive facial hair or scarring that could interfere with quantification of acne lesions
* Does not have decision making capacity
Minimum Eligible Age

12 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-01725

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison Study of Topical Acne Regimens
NCT00913185 COMPLETED PHASE4